Welcome to LookChem.com Sign In|Join Free
  • or
1-benzyl-4-(5-methoxy-4,9-dioxo-4,9-dihydronaphtho[2,3-d]isoxazol-3-yl)pyridinium bromide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1383471-07-5

Post Buying Request

1383471-07-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1383471-07-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1383471-07-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,3,4,7 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1383471-07:
(9*1)+(8*3)+(7*8)+(6*3)+(5*4)+(4*7)+(3*1)+(2*0)+(1*7)=165
165 % 10 = 5
So 1383471-07-5 is a valid CAS Registry Number.

1383471-07-5Downstream Products

1383471-07-5Relevant academic research and scientific papers

Novel heat shock protein 90 inhibitors suppress P-glycoprotein activity and overcome multidrug resistance in cancer cells

Dini?, Jelena,Podolski-Reni?, Ana,Jovanovi?, Mirna,Musso, Loana,Tsakovska, Ivanka,Pajeva, Ilza,Dallavalle, Sabrina,Pe?i?, Milica

, (2019/10/22)

Heat Shock Protein 90 (Hsp90) chaperone interacts with a broad range of client proteins involved in cancerogenesis and cancer progression. However, Hsp90 inhibitors were unsuccessful as anticancer agents due to their high toxicity, lack of selectivity against cancer cells and extrusion by membrane transporters responsible for multidrug resistance (MDR) such as P-glycoprotein (P-gp). Recognizing the potential of new compounds to inhibit P-gp function and/or expression is essential in the search for effective anticancer drugs. Eleven Hsp90 inhibitors containing an isoxazolonaphtoquinone core were synthesized and evaluated in two MDR models comprised of sensitive and corresponding resistant cancer cells with P-gp overexpression (human non-small cell lung carcinoma and colorectal adenocarcinoma). We investigated the effect of Hsp90 inhibitors on cell growth inhibition, P-gp activity and P-gp expression. Structure-activity relationship analysis was performed in respect to cell growth and P-gp inhibition. Compounds 5, 7, and 9 directly interacted with P-gp and inhibited its ATPase activity. Their potential P-gp binding site was identified by molecular docking studies. In addition, these compounds downregulated P-gp expression in MDR colorectal carcinoma cells, showed good relative selectivity towards cancer cells, while compound 5 reversed resistance to doxorubicin and paclitaxel in concentration-dependent manner. Therefore, compounds 5, 7 and 9 could be promising candidates for treating cancers with P-gp overexpression.

Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors

Bargiotti, Alberto,Musso, Loana,Dallavalle, Sabrina,Merlini, Lucio,Gallo, Grazia,Ciacci, Andrea,Giannini, Giuseppe,Cabri, Walter,Penco, Sergio,Vesci, Loredana,Castorina, Massimo,Milazzo, Ferdinando Maria,Cervoni, Maria Luisa,Barbarino, Marcella,Pisano, Claudio,Giommarelli, Chiara,Zuco, Valentina,De Cesare, Michelandrea,Zunino, Franco

experimental part, p. 64 - 75 (2012/07/30)

A series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were synthesized and found to inhibit the heat shock protein 90 (Hsp90). The compounds were tested for their binding to Hsp90 and for their effects on Hsp90 client pro

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1383471-07-5